At a glance
ClinicalIndex Comparison RecordN/ACompleted· 11 enrolled
Drug / intervention
Pre-treatment analgesia +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Evaluation of Procedural Analgesia for Out-Patient Liposonix Treatment
In Brief
A clinical study evaluating Liposonix System (Model 2) and Pre-treatment analgesia for Body Contouring. Completed, enrolled 11 participants across 1 site.
Detailed Summary
The objectives of this study are to evaluate the safety and effectiveness of procedural analgesia for improvements in tolerability of treatment with the Liposonix System.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBody Contouring
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartNov 2013
First PostedNov 2013
Primary CompletionJan 2014
TodayJul 2026
First PostedNov 25, 2013
Enrollment StartNov 1, 2013
Primary CompletionJan 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 12.6 years ago
Interventions
Liposonix System (Model 2)device
Treatment of subcutaneous adipose tissue of the abdomen using high intensity focused ultrasound (Liposonix System Model 2).
Pre-treatment analgesiadrug
Pre-treatment analgesia (combination of ondansetron, ketorolac, and hydromorphone)